Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Reproduction (2005) 129 379-389
DOI: 10.1530/rep.1.00294
Copyright © 2005 Society for Reproduction and Fertility
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pocar, P
Right arrow Articles by Hombach-Klonisch, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pocar, P
Right arrow Articles by Hombach-Klonisch, S

REVIEW

Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction

P Pocar, B Fischer, T Klonisch1 and S Hombach-Klonisch1

Department of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany and 1 Department of Human Anatomy and Cell Science, Faculty of Medicine, University of Manitoba, Winnipeg (MB) R3E0W3 Canada

Correspondence should be addressed to P Pocar; Email: paola.pocar{at}medizin.uni-halle.de


    Abstract
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
The dioxin/aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor responsive to both natural and man-made environmental compounds. AhR and its nuclear partner ARNT are expressed in the female reproductive tract in a variety of species and several indications suggest that the AhR might play a pivotal role in the physiology of reproduction. Furthermore, it appears to be the mediator of most, if not all, the adverse effects on reproduction of a group of highly potent environmental pollutants collectively called aryl hydrocarbons (AHs), including the highly toxic compound 2,3,7,8-tetrachlor-odibenzo-p-dioxin (TCDD). Although a large body of recent literature has implicated AhR in multiple signal transduction pathways, the mechanisms of action resulting in a wide spectrum of effects on female reproduction are largely unknown. Here we summarize the major types of molecular cross-talks that have been identified for the AhR and linked cell signaling pathways and that are relevant for the understanding of the role of this transcription factor in female reproduction.


    Introduction
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
The aryl hydrocarbon receptor (AhR) is a member of the basic helix–loop–helix (bHLH)-Per-ARNT-Sim (PAS) family of transcriptional regulators that control a variety of developmental and physiological events, including neurogenesis, tracheal and salivary duct formation, toxin metabolism, circadian rhythms, response to hypoxia, and hormone receptor function. The unique feature of all bHLH-PAS proteins is the PAS domain, named after the first three proteins identified with this motif, the Drosophila Per, human ARNT and Drosophila Sim (Nambu et al. 1991). The PAS domain consists of 260–310 amino acids (Crews et al. 1988) and incorporates two well-conserved hydrophobic repeats, termed PAS-A and PAS-B, separated by a poorly conserved spacer. Overall, the PAS domain is not well conserved and, given its size and diversity in sequence, can mediate a number of diverse biochemical functions. Facilitating partner selection during formation of bHLH-PAS heterodimers (Huang et al. 1993), binding small molecules (Dolwick et al. 1993), and conferring target gene specificity of bHLH-PAS heterodimers are important functions of PAS-domains (Zelzer et al. 1997).

The AhR and its nuclear partner ARNT are two founding members of the bHLH-PAS family and their dimerization to form an active transcription factor complex has become a paradigm in studying mechanisms of bHLH-PAS protein function. Unliganded AhR is located in the cytoplasm associated with heat shock protein 90 (hsp90) (Denis et al. 1988, Perdew 1988) and a 38 kDa, immunophilin-related protein (XAP2) (Carver & Bradfield 1997, Ma & Whitlock 1997, Meyer et al. 1998). Ligand binding to the AhR is presumed to produce conformational changes in the AhR protein which result in the exposure of an AhR nuclear localization signal and the translocation of the whole complex into the nucleus (Pollenz et al. 1994). Within the nucleus, the AhR–ligand complex dissociates from associated proteins and dimerizes with ARNT (Reyes et al. 1992), to reconstitute an active transcription factor which binds defined DNA sequences with high affinity. Binding of the ligand-activated AhR–ARNT transcriptionally active complex to its specific DNA recognition site, the xenobiotic-responsive element (XRE), within the promoter region of AhR-regulated genes results in their increased transcription (Denison et al. 1988). Much of our understanding of AhR function derives from analyses of the mechanisms by which its prototypical ligand 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) induces the transcription of CYP1A1. This gene encodes the microsomal enzyme cytochrome P4501A1 which oxygenates various xenobiotics as part of their stepwise detoxification (Conney 1982). Although the transcriptional activation of P450 family members by AhR ligands is well known, additional routes of AhR-mediated actions have been proposed. For instance, TCDD causes a rise in Ca2+uptake within 5 min in Hepa-1 cells which can not be explained on the basis of transcriptional changes (Puga et al. 1992). Furthermore, Enan and Matsumura (1995) demonstrated that TCDD induces changes in protein phosphorylation through the activation of protein tyrosine kinases within 10 min. This rapid effect is AhR dependent and occurs under cell-free conditions in the absence of a nucleus. On the basis of these observations a TCDD-induced protein phosphorylation pathway may be considered as a separate route of AhR signaling from the well-established nuclear translocation-dependent pathway. A scheme of the two different signaling pathways of the AhR upon ligand binding is shown in Fig. 1Go.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1 Binding of the ligand to the AhR results in the release of associated proteins and translocation to the nucleus followed by dimerization with ARNT. The AhR–ARNT complex binds the XRE promoting target gene transcription. Ligands can also exert their effects in the cytoplasm through AhR-associated protein kinases to alter the function of a variety of proteins through a cascade of protein phosphorylation.

 
AhR ligands such as TCDD, coplanar polychlorinated biphenyls (PCBs) and dibenzo[a]antracene (DBMA), are widespread in the environment, potent toxicants and resistant to metabolic breakdown (examples of AhR ligands are shown in Fig. 2Go). The latter property is responsible for the accumulation of these compounds in the food chain and their sustained effects on animal and human health, including reproductive functions (Fischer 2000, Stapleton & Baker 2003). The induction of xenobiotic-metabolizing enzymes is considered an adaptive cellular response aimed at detoxifying lipophilic foreign compounds. Other responses to AhR ligands include alterations in endocrine homeostasis, cellular proliferation and tissue differentiation; these responses are associated with adverse health effects (Poland & Knutson 1982, Safe 1986, Peterson et al. 1993, Huff et al. 1994).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2 Molecular structure of some AhR ligands.

 
Reproduction and developmental processes reflect an intricate and highly regulated chain of events and require the precise integration of a functional endocrine system. Exogenous environmental chemicals that mimic, inhibit or modulate endogenous endocrine messengers may inevitably disturb reproductive functions. TCDD and related compounds have been demonstrated to alter cell growth and differentiation, and to affect homeostasis and hormone balance by modulating the induction of enzymes, growth factors and hormones as well as their cognate receptors (DeVito & Birnbaum 1995). In addition, these xenobiotic compounds can act in an estrogenic or anti-estrogenic manner (Safe & Krishnan 1995), alter the levels of thyroxin (Van Birgelen et al. 1995) and several growth factors – including their cognate receptors (Abbott & Birnbaum 1990, Dohr et al. 1994) – or modulate the expression of glucocorticoids (Abbott 1995).

This review summarizes AhR-mediated cellular responses in the female reproductive tract, particularly focusing on the molecular cross-talk identified between AhR and other cell signaling pathways.


    AhR cross-talk with steroid hormone receptors
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
Most AhR/steroid receptor interactions have been studied in human breast cancer and endometrial carcinoma cell lines. The liganded AhR targets specific genomic core inhibitory dioxin/xenobiotic responsive elements (iDRE/iXRE). Functional iXREs are present within the promoter regions of the estrogen-inducible pS2, cathepsin D and c-fos genes (Safe et al. 2000). In HEC-1A human endometrial carcinoma cells, AhR–ARNT complexes competitively inhibit the binding of ER-alpha to imperfect Estrogen response element (ERE) sites adjacent to or overlapping with XRE sites (Klinge et al. 1999). TCDD-activated AhR inhibits estradiol (E2)-induced cathepsin D expression in MCF-7 breast cancer adenocarcinoma cells by binding to an iXRE within the promoter of the cathepsin D gene, thus preventing the formation of a transcriptionally active ER-SP1 complex (Duan et al. 1999, Wang et al. 2001). A similar AhR-mediated inhibitory AhR/ER cross-talk was demonstrated for the c-fos protooncogene promoter in MCF-7 (Safe et al. 2000). Liganded AhR–ARNT and ligand-activated ER-alpha do not directly interact but both ligand-activated transcription factor complexes can physically interact with and compete for SP1 protein (Kobayashi et al. 1996, Wang et al. 1998a). The liganded AhR was also shown to inhibit binding of ER-alpha to an ERE in the pS2 promoter by interaction with Activator protein-1 (AP-1) proteins (Gillesby et al. 1997). AP-1 consists of a heterodimer of c-jun and c-fos and promotes the binding of liganded ER-alpha to AP-1 DNA binding sites. Interaction of liganded AhR with AP-1 proteins promotes binding to a XRE/AP-1-like motif and, at the same time, prevents binding of ER-alpha to a neighboring ERE. Thus, AhR can function as a ligand-activated transcriptional repressor by binding to iXRE overlapping or neighboring ERE/AP-1 sites or ERE/SP1 sites respectively, quenching transcriptionally active ER/SP1 or ER/AP-1 complexes (Fig. 3AGo).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 3 (A) Mechanisms of genomic inhibition of steroid-mediated transcription by ligand-activated AhR. Transcriptional inhibition depends on iXREs within promoter regions of estrogen-regulated genes which prevent ER transcriptional activity by: (a) being located close by to neighboring EREs; (b) disrupting the formation of ER–SP-1 or ER–AP-1 DNA complexes; and (c) competing for limited cofactors (e.g. NF-1). These mechanisms apply to interactions of the AhR with all sex steroid hormone receptors interactions and are shown here for the estrogen receptor (ER). (B) Activation of AhR by exogenous ligands can rapidly reduce the levels of ER protein by proteasomal degradation. The exact mechanism by which liganded AhR initiates that degradation is presently unknown. (C) AhR-mediated mechanisms leading to the activation of sex steroid hormone signaling in the absence of estrogen. (a) Upon binding of the ligand, a conformational change causes the release of active c-Src from the cytoplasmic AhR–protein complex. c-Src activates several protein kinases leading to phosphorylation and activation of ER. (b) A direct association of AhR–ARNT complexes with nuclear ER and the cofactor p300/CBP in the absence of E2. (c) Activation of steroid hormone receptor by direct protein interaction with the AhR–ARNT complex in the absence of hormone has so far only been observed for the ER.

 
A rapid proteasome-mediated degradation of AhR and ER-alpha by activated AhR as another facette of an inhibitory AhR-ER-alpha cross-talk has been demonstrated in T47D human breast cancer cells (Fig. 3BGo). The extent of AhR-mediated activation of proteasomal degradation is ligand dependent with the classical AhR ligand TCDD displaying stronger effects as compared with AhR ligands such as benzo[a ]pyrene (BaP) or 6-methyl-1,3,8-trichlorodiben-zofuran (MCDF) (Wormke et al. 2000). In ECC-1 endometrial carcinoma cells exposed to TCDD, Ricci et al.(1999) also described an AhR-mediated reduction in ER-alpha protein and ER-alpha-mediated transcriptional activity. By contrast, TCDD-activated AhR did not reduce ER-alpha protein in the endometrial carcinoma cells KLE and RL95-2, suggesting that proteasomal degradation varies according to the specific cellular background (Sone & Yonemoto 2002). Reduced ER-alpha protein levels have been described for several human endometrial pathologies. For example, down-regulation of ER-alpha is an important finding in human endometriosis tissues (Brandenberger et al. 1999, Fujimoto et al. 2000, 2002), in human endometrial adenocarcinomas and also in poorly differentiated mixed mullerian tumors (Jazaeri et al. 2001). Reducing ER-alpha protein or ER-alpha transcriptional activity within the endometrium via inhibitory AhR/ER-alpha cross-talk might have a severe impact on endometrial physiology. It may result in decreased PR expression, an important E2-target molecule within the endometrium, diminishing the actions of progesterone (P4) on endometrial differentiation during the secretory phase of the cycle. TCDD has been shown to decrease P4-induced and transforming growth factor (TGF)-beta-mediated reduction of matrix metalloproteinase (MMP)-3 and MMP-7 during the secretory phase thus promoting experimental endometriosis (Bruner-Tran et al. 1999). TCDD causes increased expression of interleukin-1(IL-1)beta and plasminogen activator-inhibitor-2 (PAI-2) mRNA and a dose-dependent decrease in AhR gene activity in cultured human endometrial stromal cells (Yang 1999). Although the role of PAI-2 in promoting migration of tumor cells is well established (Morita et al. 1999), a definitive function of TCDD in the progression of endometrial carcinoma is unclear.

In human MCF-7 breast cancer cells, agonist-activated AhR–ARNT complexes have been shown to associate directly with ER-alpha and ER-beta in the absence of estrogen resulting in transcriptional activation of ERE-dependent genes (Ohtake et al. 2003). This ERE-dependent estrogenic effect of liganded AhR requires direct interaction of the nuclear AhR–ARNT complex with unliganded ER and the cofactor p300/CBP (Fig. 3CGo). By contrast, in the presence of estrogen, liganded AhR exhibits anti-estrogenic effects by suppressing estrogen-bound ER-mediated DNA binding. These results strongly indicate that the AhR-mediated regulation of estrogenic effects depends on the concentration of estrogens. This may partially explain the weak estrogenic effects of PCB 126 in the uterus of ovariectomized, as opposed to normal, rats (Lind et al. 1999).

Apart from its transcriptional activity and independent of its nuclear localization, ligand-bound AhR appears to act via a second pathway which is located in the cytoplasm. Unliganded AhR in the cytoplasm is associated with HSP90, XAP2, p23 and the tyrosine kinase c-Src (pp60src). Upon ligand binding, active c-Src appears to be released from this aggregate resulting in the stimulation of other protein kinases (Perdew 1988, Hutchison et al. 1992, Matsumura 1994, Vogel & Matsumura 2003). Active c-Src may phosphorylate and activate steroid receptors such as ER resulting in estrogenic effects in the absence of estrogens. Thus, by triggering protein kinases ligand-activated AhR may elicit multiple and unpredicted cellular responses (see reviews of Matsumura 1994, and Carlson and Perdew 2002).

Apart from the studies mentioned above, to date there have been only a few reports on the cross-talk between AhR and ER in reproductive-related cells. In porcine follicular cells, recent studies indicate a TCDD-induced decrease in estrogen synthesis and that the exposure to the action of AhR or ER blockers (alpha naphthoflavone and 4-OH-tamoxifen respectively) is able to completely reverse the inhibitory effect (Gregoraszczuk 2002). A further report indicates a potentiation of TCDD activity through contemporary exposure to estradiol in mouse ovarian cells, and that this effect can be reversed through exposure to specific ER blockers (Son et al. 2002). Despite the fact that the precise molecular mechanisms involved in these phenomena have not been yet further investigated, these studies strongly suggest that a positive cross-talk between the two signaling pathways exists in ovarian cells.

Investigations on the interaction of AhR with other steroid hormone receptors have revealed a bi-directional cross-talk. Recently, an anti-androgenic effect of ligand-activated AhR was described in LNCaP prostate cancer cells. Interaction of the AhR ligand complex with AP-1 proteins resulted in diminished induction of prostate-specific-antigen (PSA) by testosterone. However, this was not caused by a decrease in intracellular levels of the androgen receptor (AR) or concentrations of intracellular dihydrotestosterone (DHT) (Kizu et al. 2003). Although this interaction was shown in LNCaP human prostate cancer cells, the presence of AR within the ovary (Pelletier et al. 2000) and endometrium (Slayden et al. 2001, Apparao et al. 2002, Brenner et al. 2002) would suggest the presence of a potential AhR/AR cross-talk to also be effective within female reproductive organs.

On the other hand, steroid hormone receptors can also inhibit AhR signal transduction and this inhibitory nuclear receptor cross-talk is caused by competition of AhR and ER for the rate-limiting co-regulators ERAP140 and SMRT (Nguyen et al. 1999). In the human endometrial carcinoma cell line ECC-1, competition was described for nuclear factor-1 (NF-1), a transcription factor capable of binding both ER-alpha and AhR. Competitive binding of NF-1 by estrogen-activated ER resulted in diminished TCDD-mediated CYP1A1 transcriptional activation (Ricci et al. 1999). A unidirectional inhibitory progesterone receptor (PR)/AhR cross-talk involves both PR isoforms, PR-A and PR-B, and repression of AhR–ARNT transcriptional activity requires the active progesterone responsive element (PRE)-binding form of PR-B, but not PR-A (Kuil et al. 1998).

In conclusion, AhR activation can result in the inhibition or promotion of steroid hormone signaling in reproductive tissues and this may, in part, explain the contradictory results of estrogenic or anti-estrogenic effects mediated by AhR ligands. Environmental AhR ligands have been implicated in promoting endometriosis and endometrial cancer in various species (Cummings et al. 1996, Johnson et al. 1997, Mann 1997, Mayani et al. 1997, Rier 2002). Yet, epidemiological data from the accidental exposure to TCDD in Seveso, Italy (1976), have revealed a decrease in the incidence of endometrial carcinoma in TCDD-exposed women (Bertazzi et al. 1997). Similarly, TCDD appears to have a breast cancer protective function (Greenlee et al. 2001). The molecular mechanisms by which TCDD exerts these anti-tumorigenic effects are unknown.


    Cell cycle and apoptosis
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
It is now clear that the AhR plays a pivotal role in cell cycle regulation (Ma & Whitlock 1996, Vaziri & Faller 1997, Puga et al. 2002) and apoptosis (Zaher et al. 1998, Reiners & Clift 1999). The inhibition of estrogen-mediated induction of cell cycle activators such as cyclin D1 and the activation by liganded AhR of CDK2, CDK4 and CDK7 (Wang et al. 1998b) suggest a supportive role for AhR in E2-dependent tumor growth in the female reproductive tract (Bertazzi et al. 1997). However, the AhR also has a direct influence on the cell cycle by induction of the cyclin/cdk inhibitor p27 (Kip1) as demonstrated in rat 5L hepatoma cells (Ge & Elferink 1998). Upon nuclear translocation, liganded AhR engages in a protein–protein interaction with retinoblastoma protein (pRb) via two binding motifs: a high-affinity LXCXE motif located within the N-terminal 364 amino acids and a low-affinity binding site located within the glutamine-rich transactivation domain of the AhR. Ligand-activated AhR binds preferentially to hypophosphorylated Rb (pRb) which represents the active form of Rb leading to G1 arrest in rat L5 hepatoma cells (Ge & Elferink 1998). AhR synergizes with pRb in potentiating the repression of E2F-dependent transcription inducing cell cycle arrest (Puga et al. 2000). As hypophosphorylated Rb is limited to G0 and G1 phases of the cell cycle, so is pRb-dependent AhR action (Elferink et al. 2001). In MCF-7 cells, the direct interaction of liganded AhR with hypophosphorylated Rb was shown to be independent of ARNT and therefore does not require XRE-mediated transcriptional activity. This non-genomic function of AhR deserves further investigation, since alterations in cell cycle progression in exposed tissues by potential endogenous (Carlson & Perdew 2002) and environmental AhR ligands may contribute significantly to the physiological roles of this bHLH transcription factor.

At or near the G1/S boundary lays the point of divergence between continuation of the cell cycle and apoptosis. Apoptosis plays a critical role in reproduction, during development and in the maintenance of tissue and organ homeostasis (Scott et al. 1996, Jacobson et al. 1997) and many toxicants exert their cytotoxic effects by virtue of apoptosis. Several studies implicate the fine-tuned balance between the levels of AhR battery enzymes and the AhR as an important factor in aiding the cell to choose between apoptosis and continued cell proliferation. Immunohistochemical analysis of embryonic tissues showed that AhR expression is developmentally regulated and occurs in regions undergoing tissue remodeling processes (Abbott et al. 1995). Up-regulation of AhR and ARNT expression was observed during early outgrowth and elevation of palatal shelves. In addition, altered relative expression of these two bHLH transcription factor genes was observed after exposure to TCDD and this correlated with a higher incidence of cleft palate in developing mice (Abbott et al. 1999). Furthermore, stimulation of resting T cells with mitogens resulted in a marked increase of AhR expression paralleled by an increase in apoptosis (Crawford et al. 1997). Comparisons of the sensitivities of AhR +/+ and AhR –/– mice to the exposure of TCDD revealed thymic atrophy as a result of T-cell apoptosis in wild-type mice, but not in TCDD-resistant AhR –/– mice (Fernandez-Salguero et al. 1996, Kamath et al. 1997). Also, reduced liver size in AhR null mice was associated with incidence of apoptosis (Zaher et al. 1998). Several other studies have demonstrated the ability of a variety of AhR ligands – such as DMBA, BaP and TCDD – to induce apoptosis in various cell types of non-reproductive tissues, including pre-B cells (Jyonouchi et al. 1999), Hepa1c1c7 murine hepatoma cells (Lei et al. 1998) and mouse epidermis (Miller et al. 1996). However, the molecular mechanisms by which these chemical compounds induce programmed cell death remain unclear.

In the ovary, apoptosis is the principal mechanism by which oocyte depletion is mediated under both normal and pathologic conditions (Perez & Tilly 1997, Morita & Tilly 1999, Pru & Tilly 2001). It has been known for over two decades now that exposure of female mice to AhR ligands causes a rapid depletion of primordial and primary oocytes (Mattison et al. 1989) and these ovotoxic effects can be prevented by selective AhR antagonists (Shiromizu & Mattison 1985). Thus, it is tempting to suggest that in the ovary genes involved in the regulation of cell death are prime targets for the transcriptional regulation by the activated AhR. This hypothesis is supported by Heimler et al. 1998 who demonstrated that TCDD not only disrupts ovarian steroid production but, at the same time, is able to induce apoptosis in human follicular granulosa cells. Moreover, Matikainen and co-workers (2001) have recently reported two XRE binding sites for the AhR–ARNT complex in the promoter of the pro-apoptotic gene, Bax. Production of Bax protein and subsequent Bax-dependent increase in apoptosis are increased in murine oocytes upon exposure to the AhR ligand DMBA, but not with TCDD (Matikainen et al. 2001). Further analyses have shown that substitution of the existing guanine or cytosine to an adenine three bases downstream of the core XRE sequence renders the Bax promoter inducible by TCDD. These data elegantly demonstrate the ligand-dependent discrimination of DNA response elements (Matikainen et al. 2001).

There are only a few studies investigating the impact of AhR-mediated apoptosis in female reproductive tissues other than the ovary. Flaws et al.(1997) demonstrated that in utero exposure to TCDD induces cleft clitoris and vaginal threads of mesenchymal tissue in female rat offspring, indicating a disturbed balance between proliferation and apoptosis during the development of female genitalia.


    AhR and the regulation of the hypothalamopituitary–gonadal (HPG) axis
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
AhR-mediated actions can affect the regulation of the HPG axis by altering the secretion pattern of preovulatory follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion in primed female rats exposed to TCDD or related AhR ligands (Li et al. 1995, Gao et al. 1999). Exposure to environmentally relevant concentrations of TCDD induces a significant reduction of FSH and LH during the preovulatory period in rats (Gao et al. 1999), strongly suggesting that the reproductive toxicity of TCDD can in part be related to a dysregulation of the hypothalamo-hypophyseal axis by mechanism(s) not yet completely understood. The observation that treatment with exogenous gonadotropin-releasing hormone (GnRH) partially overcomes the blockage of preovulatory surges of LH and FSH after TCDD exposure (Gao et al. 2000) may indicate insufficient production in and/or release of GnRH from the hypothalamus as a result of TCDD action to the central nervous system (CNS). This TCDD-induced inhibition of gonadotropin surges has been explained by a decreased responsiveness of the hypothalamus to the positive feedback of estrogens, without affecting preovulatory serum estrogen levels (Gao et al. 2001). This hypothesis is confirmed by the observation that tenfold higher than physiological serum concentrations of estrogens completely reverse the TCDD effects on gonadotropin secretion (Gao et al. 2001). This latter effect can be blocked by the partial estrogen antagonist tamoxifen providing further evidence for a functional relationship between both the aryl hydrocarbon- and estrogen-mediated signaling pathways.

Members of the AhR signaling pathway are expressed in the preoptic area of the brain (POA), a region known to control reproductive functions (Petersen et al. 2000). The distribution pattern of AhR gene expression closely overlaps with that of glutamic acid decarboxylase (GAD) 67, the enzyme necessary for gamma-aminobutyric acid (GABA) synthesis. Interestingly, the GAD 67 gene contains multiple canonical XRE sequences (Erlander et al. 1991, Pinal et al. 1997). GAD 67 mRNA levels in the rostral POA/anteroventral periventricular nucleus (rPOA/AVPV) and in the rostral portion of the medial preoptic nucleus (MPN) are higher in females than in males (Hays et al. 2002). GABAergic neurons in the AVPV play a role in onset of puberty, the E2-dependent gonadotropin surge and in ovulation. Developmental exposure to TCDD can specifically down-regulate GAD 67 expression in the rPOA/AVPV in female rats resulting in abolished sexual differentiation of this area. In utero exposure of female rats to TCDD induces delayed onset of puberty and increases the time required to achieve pregnancy in a continuous mating situation (Gray & Ostby 1995, Gray et al. 1997). Thus, sex- and region-specific suppression of GABA synthesis in the CNS adds to the multiple cellular actions by which TCDD can disrupt female reproductive functions.


    Evidence for a physiological role of AhR in reproduction
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
Many attempts have been made to identify endogenous ligands that could trigger AhR-dependent signaling under physiological conditions. However, with the exception of the tryptophane analogs indirubin and indigo, which have been recently identified in human urine (Adachi et al. 2001), and 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester in the porcine lung (Song et al. 2002), the nature of endogenous AhR ligands remains elusive. The attempt to assess the role of the AhR in the absence of activation by xenobiotic compounds led to the production of AhR-deficient mice from three independent research groups (Fernandez-Salguero et al. 1995, Schmidt et al. 1996, Mimura et al. 1997). Those AhR-knockout animal models demonstrated a range of complex reproductive deficiencies in female mice in the absence of AhR gene expression. These adverse reproductive parameters included deaths of the –/– females during pregnancy and lactation, small litter size at birth, poor survival of pups during the first 2 weeks after birth, and death of –/– pups after weaning. The poor reproductive success in these AhR-null animals possibly reflects the disruption of multiple biological processes. A more extensive analysis of older AhR –/– animals showed hypertrophic uteri displaying thrombosis and mineralization of the serosal vessels coinciding with a reduction of the litter size (Fernandez-Salguero et al. 1997). In addition, increased numbers of primordial follicles were detected in 2- to 3- or 4-day-old AhR –/– females (Benedict et al. 2000, Robles et al. 2000). Female AhR-null mice at 53 days of age displayed a decreased number of antral follicles (Benedict et al. 2000) and a resistance of germ cells to undergo apoptosis (Robles et al. 2000). These results indicate that the decreased number of antral follicles observed in the AhR –/– mice may be insufficient to support the hormone synthesis needed during pregnancy and lactation. Furthermore, a recent study by Benedict et al.(2003) suggested that AhR deletion impairs follicular growth and, concomitantly, reduces the number of follicles that ovulate and become corpora lutea. This would implicate AhR as a novel regulator of ovulation. In agreement with this hypothesis, the ovulatory gonadotropin surge has been shown to induce the expression of AhR gene activity in the macaque ovary (Chaffin et al. 1999) and we have recently demonstrated the AhR-mediated induction of CYP1A1 in the absence of exogenous ligands in in-vitro matured bovine oocytes, suggesting a direct role of the AhR signaling pathway in the resumption of meiosis in mammalian oocytes (Pocar et al. 2004).

Thus, the bHLH transcription factor AhR appears to have a prominent functional role in female reproduction that deserves further attention.


    Conclusions
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 
It is clear now that the many complex reproductive effects of dioxins and related compounds observed in mammals reflect four important findings:

  1. Although the biological effects of dioxin-like compounds require the AhR, the role of this bHLH transcription factor extends beyond the activation of the AhR gene battery and includes also non-genomic pathways.
  2. There exists an intricate network of interactions, direct and indirect, between sex steroid receptors and the AhR–ARNT system which can modify reproductive processes.
  3. AhR-mediated actions affect all levels of a reproductive system, from the HPG axis to the reproductive organs themselves, causing adaptive short-term and irreversible long-term effects on the reproductive system.
  4. Developmental and transgenic mouse studies have clearly demonstrated that the AhR transcription factor is more than just a xenobiotic sensor but potentially an integral key component of normal reproductive physiology.

The complex role of the AhR in female reproduction is still largely elusive. A multidisciplinary approach with areas of expertise in toxicology, pathology, endocrinology and molecular/developmental biology will be required to further unveil the secrets of the role of AhR in reproduction of the female.


    Footnotes
 
Received 28 April 2004
First decision 22 July 2004
Revised manuscript received 7 December 2004
Accepted 7 December 2004


    References
 Top
 Abstract
 Introduction
 AhR cross-talk with steroid...
 Cell cycle and apoptosis
 AhR and the regulation...
 Evidence for a physiological...
 Conclusions
 References
 

Abbott BD 1995 Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology 105 365–373.[CrossRef][ISI][Medline]

Abbott BD & Birnbaum LS 1990 TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicology and Applied Pharmacology 106 418–432.[CrossRef][ISI][Medline]

Abbott BD, Birnbaum LS & Perdew GH 1995 Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Developmental Dynamics 204 133–143.[ISI][Medline]

Abbott BD, Held GA, Wood CR, Buckalew AR, Brown JG & Schmid J 1999 AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicological Sciences 47 62–75.[Abstract/Free Full Text]

Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA 3rd, Kato T, Saeki K & Matsuda T 2001 Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. Journal of Biological Chemistry 276 31475–31478.[Abstract/Free Full Text]

Apparao KB, Lovely LP, Gui Y, Lininger RA & Lessey BA 2002 Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biology of Reproduction 66 297–304.[Abstract/Free Full Text]

Benedict JC, Lin TM, Loeffler IK, Peterson RE & Flaws JA 2000 Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicological Sciences 56 382–388.[Abstract/Free Full Text]

Benedict JC, Miller KP, Lin TM, Greenfeld C, Babus JK, Peterson RE & Flaws JA 2003 Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biology of Reproduction 68 1511–1517.[Abstract/Free Full Text]

Bertazzi PA, Zocchetti C, Guercilena S, Consonni D, Tironi A, Landi MT & Pesatori AC 1997 Dioxin exposure and cancer risk: a 15-year mortality study after the ‘Seveso accident’. Epidemiology 8 646–652.[CrossRef][ISI][Medline]

Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB & Taylor RN 1999 Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Molecular Human Reproduction 5 651–655.[Abstract/Free Full Text]

Brenner RM, Slayden OD & Critchley HO 2002 Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor. Reproduction 124 167–172.[Abstract]

Bruner-Tran KL, Rier SE, Eisenberg E & Osteen KG 1999 The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecologic and Obstetric Investigation 48 (Suppl 1) 45–56.

Carlson DB & Perdew GH 2002 A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. Journal of Biochemical and Molecular Toxicology 16 317–325.[CrossRef][ISI][Medline]

Carver LA & Bradfield CA 1997 Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. Journal of Biological Chemistry 272 11452–11456.[Abstract/Free Full Text]

Chaffin CL, Stouffer RL & Duffy DM 1999 Gonadotropin and steroid regulation of steroid receptor and aryl hydrocarbon receptor messenger ribonucleic acid in macaque granulosa cells during the periovulatory interval. Endocrinology 140 4753–4760.[Abstract/Free Full Text]

Conney AH 1982 Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Research 42 4875–4917.[Free Full Text]

Crawford RB, Holsapple MP & Kaminski NE 1997 Leukocyte -activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Molecular Pharmacology 52 921–927.[Abstract/Free Full Text]

Crews ST, Thomas JB & Goodman CS 1988 The Drosophila single-minded gene encodes a nuclear protein with sequence similarity to the per gene product. Cell 52 143–151.[CrossRef][ISI][Medline]

Cummings AM, Metcalf JL & Birnbaum L 1996 Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicology and Applied Pharmacology 138 131–139.[CrossRef][ISI][Medline]

Denis M, Cuthill S, Wikstrom AC, Poellinger L & Gustafsson JA 1988 Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochemical and Biophysical Research Communications 155 801–807.[CrossRef][ISI][Medline]

Denison MS, Fisher JM & Whitlock JP Jr 1988 The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. Journal of Biological Chemistry 263 17221–17224.[Abstract/Free Full Text]

DeVito MJ & Birnbaum LS 1995 Dioxins: model chemicals for assessing receptor-mediated toxicity. Toxicology 102 115–123.[CrossRef][ISI][Medline]

Dohr O, Vogel C & Abel J 1994 Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Experimental and Clinical Immunogenetics 11 142–148.[ISI][Medline]

Dolwick KM, Swanson HI & Bradfield CA 1993 In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. PNAS 90 8566–8570.[Abstract/Free Full Text]

Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M & Safe S 1999 Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Molecular Endocrinology 13 1511–1521.[Abstract/Free Full Text]

Elferink CJ, Ge NL & Levine A 2001 Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Molecular Pharmacology 59 664–673.[Abstract/Free Full Text]

Enan E & Matsumura F 1995 Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochemical Pharmacology 49 249–261.[CrossRef][ISI][Medline]

Erlander MG, Tillakaratne NJ, Feldblum S, Patel N & Tobin AJ 1991 Two genes encode distinct glutamate decarboxylases. Neuron 7 91–100.[CrossRef][ISI][Medline]

Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM & Gonzalez FJ 1995 Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 722–726.[Abstract/Free Full Text]

Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM & Gonzalez FJ 1996 Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology 140 173–179.[CrossRef][ISI][Medline]

Fernandez-Salguero PM, Ward JM, Sundberg JP & Gonzalez FJ 1997 Lesions of aryl-hydrocarbon receptor-deficient mice. Veterinary Pathology 34 605–614.[Abstract]

Fischer B 2000 Receptor-mediated effects of chlorinated hydrocarbons. Andrologia 32 279–283.[CrossRef][ISI][Medline]

Flaws JA, Sommer RJ, Silbergeld EK, Peterson RE & Hirshfield AN 1997 In utero and lactational exposure to 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) induces genital dysmorphogenesis in the female rat. Toxicology and Applied Pharmacology 147 351–362.[CrossRef][ISI][Medline]

Fujimoto J, Sakaguchi H, Aoki I, Khatun S, Toyoki H & Tamaya T 2000 Steroid receptors and metastatic potential in endometrial cancers. Journal of Steroid Biochemistry and Molecular Biology 75 209–212.[CrossRef][ISI][Medline]

Fujimoto J, Sakaguchi H, Aoki I, Toyoki H & Tamaya T 2002 Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology 62 269–277.[CrossRef][ISI][Medline]

Gao X, Son DS, Terranova PF & Rozman KK 1999 Toxic equivalency factors of polychlorinated dibenzo-p-dioxins in an ovulation model: validation of the toxic equivalency concept for one aspect of endocrine disruption. Toxicology and Applied Pharmacology 157 107–116.[CrossRef][ISI][Medline]

Gao X, Petroff BK, Rozman KK & Terranova PF 2000 Gonadotropin-releasing hormone (GnRH) partially reverses the inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on ovulation in the immature gonadotropin-treated rat. Toxicology 147 15–22.[CrossRef][ISI][Medline]

Gao X, Mizuyachi K, Terranova PF & Rozman KK 2001 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases responsiveness of the hypothalamus to estradiol as a feedback inducer of preovulatory gonadotropin secretion in the immature gonadotropin-primed rat. Toxicology and Applied Pharmacology 170 181–190.[CrossRef][ISI][Medline]

Ge NL & Elferink CJ 1998 A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. Journal of Biological Chemistry 273 22708–22713.[Abstract/Free Full Text]

Gillesby BE, Stanostefano M, Porter W, Safe S, Wu ZF & Zacharewski TR 1997 Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry 36 6080–6089.[CrossRef][Medline]

Gray LE Jr & Ostby JS 1995 In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicology and Applied Pharmacology 133 285–294.[CrossRef][ISI][Medline]

Gray LE, Wolf C, Mann P & Ostby JS 1997 In utero exposure to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin alters reproductive development of female Long Evans hooded rat offspring. Toxicology and Applied Pharmacology 146 237–244.[CrossRef][ISI][Medline]

Greenlee WE, Hushka LJ & Hushka DR 2001 Molecular basis of dioxin actions: evidence supporting chemoprotection. Toxicologic Pathology 29 6–7.[CrossRef][ISI][Medline]

Gregoraszczuk EL 2002 Dioxin exposure and porcine reproductive hormonal activity. Cadernos de Saude Publica 18 453–462.

Hays LE, Carpenter CD & Petersen SL 2002 Evidence that GABAergic neurons in the preoptic area of the rat brain are targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin during development. Environmental Health Perspectives 110 (Suppl 3) 369–376.

Heimler I, Rawlins RG, Owen H & Hutz RJ 1998 Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 139 4373–4379.[Abstract/Free Full Text]

Huang ZJ, Edery I & Rosbash M 1993 PAS is a dimerization domain common to Drosophila period and several transcription factors. Nature 364 259–262.[CrossRef][Medline]

Huff J, Lucier G & Tritscher A 1994 Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence. Annual Review of Pharmacology and Toxicology 34 343–372.[ISI][Medline]

Hutchison KA, Brott BK, De Leon JH, Perdew GH, Jove R & Pratt WB 1992 Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free system. Journal of Biological Chemistry 267 2902–2908.[Abstract/Free Full Text]

Jacobson MD, Weil M & Raff MC 1997 Programmed cell death in animal development. Cell 88 347–354.[CrossRef][ISI][Medline]

Jazaeri AA, Nunes KJ, Dalton MS, Xu M, Shupnik MA & Rice LW 2001 Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression. Oncogene 20 6965–6969.[CrossRef][ISI][Medline]

Johnson KL, Cummings AM & Birnbaum LS 1997 Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls. Environmental Health Perspectives 105 750–755.[ISI][Medline]

Jyonouchi H, Sun S, Iijima K, Wang M & Hecht SS 1999 Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol. Carcinogenesis 20 139–145.[Abstract/Free Full Text]

Kamath AB, Xu H, Nagarkatti PS & Nagarkatti M 1997 Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetra-chlorodibenzo-p-dioxin in vivo. Toxicology and Applied Pharmacology 142 367–377.[CrossRef][ISI][Medline]

Kizu R, Okamura K, Toriba A, Kakishima H, Mizokami A, Burnstein KL & Hayakawa K 2003 A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Archives of Toxicology 77 335–343.[ISI][Medline]

Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK & Swanson HI 1999 The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Molecular and Cellular Endocrinology 157 105–119.[CrossRef][ISI][Medline]

Kobayashi A, Sogawa K & Fujii-Kuriyama Y 1996 Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene. Journal of Biological Chemistry 271 12310–12316.[Abstract/Free Full Text]

Kuil CW, Brouwer A, van der Saag PT & van der Burg B 1998 Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms. Journal of Biological Chemistry 273 8829–8834.[Abstract/Free Full Text]

Lei W, Yu R, Mandlekar S & Kong AN 1998 Induction of apoptosis and activation of interleukin 1beta-converting enzyme/Ced-3 protease (caspase-3) and c-Jun NH2-terminal kinase 1 by benzo(a)pyrene. Cancer Research 58 2102–2106.[Abstract/Free Full Text]

Li X, Johnson DC & Rozman KK 1995 Reproductive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female rats: ovulation, hormonal regulation, and possible mechanism(s). Toxicology and Applied Pharmacology 133 321–327.[CrossRef][ISI][Medline]

Lind PM, Eriksen EF, Sahlin L, Edlund M & Orberg J 1999 Effects of the antiestrogenic environmental pollutant 3,3' ,4,4', 5-penta-chlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals. Toxicology and Applied Pharmacology 154 236–244.[CrossRef][ISI][Medline]

Ma Q & Whitlock JP Jr 1996 The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Molecular and Cellular Biology 16 2144–2150.[Abstract]

Ma Q & Whitlock JP Jr 1997 A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetra-chlorodibenzo-p-dioxin. Journal of Biological Chemistry 272 8878–8884.[Abstract/Free Full Text]

Mann PC 1997 Selected lesions of dioxin in laboratory rodents. Toxicologic Pathology 25 72–79.[ISI][Medline]

Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH & Tilly JL 2001 Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genetics 28 355–360.[CrossRef][ISI][Medline]

Matsumura F 1994 How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochemical Pharmacology 48 215–224.[CrossRef][ISI][Medline]

Mattison DR, Singh H, Takizawa K & Thomford PJ 1989 Ovarian toxicity of benzo(a)pyrene and metabolites in mice. Reproductive Toxicology 3 115–125.[CrossRef][ISI][Medline]

Mayani A, Barel S, Soback S & Almagor M 1997 Dioxin concentrations in women with endometriosis. Human Reproduction 12 373–375.[Abstract/Free Full Text]

Meyer BK, Pray-Grant MG, Vanden Heuvel JP & Perdew GH 1998 Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Molecular and Cellular Biology 18 978–988.[Abstract/Free Full Text]

Miller ML, Andringa A, Cody T, Dixon K & Albert RE 1996 Cell proliferation and nuclear abnormalities are increased and apoptosis is decreased in the epidermis of the p53 null mouse after topical application of benzo[a]pyrene. Cell Proliferation 29 561–576.[ISI][Medline]

Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M & Fujii-Kuriyama Y 1997 Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2 645–654.[Abstract]

Morita Y & Tilly JL 1999 Oocyte apoptosis: like sand through an hourglass. Developmental Biology 213 1–17.[CrossRef][ISI][Medline]

Morita Y, Hayashi Y, Kanamaru T, Itoh T, Suzuki S, Yamamoto M, Kuroda Y & Itoh H 1999 Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells. Japanese Journal of Cancer Research 90 747–752.[CrossRef][ISI][Medline]

Nambu JR, Lewis JO, Wharton KA Jr & Crews ST 1991 The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell 67 1157–1167.[CrossRef][ISI][Medline]

Nguyen TA, Hoivik D, Lee JE & Safe S 1999 Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Archives of Biochemistry and Biophysics 367 250–257.[CrossRef][ISI][Medline]

Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y & Kato S 2003 Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423 545–550.[CrossRef][Medline]

Pelletier G, Labrie C & Labrie F 2000 Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. Journal of Endocrinology 165 359–370.[Abstract]

Perdew GH 1988 Association of the Ah receptor with the 90-kDa heat shock protein. Journal of Biological Chemistry 263 13802–13805.[Abstract/Free Full Text]

Perez GI & Tilly JL 1997 Cumulus cells are required for the increased apoptotic potential in oocytes of aged mice. Human Reproduction 12 2781–2783.[Abstract/Free Full Text]

Petersen SL, Curran MA, Marconi SA, Carpenter CD, Lubbers LS & McAbee MD 2000 Distribution of mRNAs encoding the arylhydrocarbon receptor, arylhydrocarbon receptor nuclear translocator, and arylhydrocarbon receptor nuclear translocator-2 in the rat brain and brainstem. Journal of Comparative Neurology 427 428–439.[CrossRef][ISI][Medline]

Peterson RE, Theobald HM & Kimmel GL 1993 Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Critical Reviews in Toxicology 23 283–335.[ISI][Medline]

Pinal CS, Cortessis V & Tobin AJ 1997 Multiple elements regulate GAD65 transcription. Developmental Neuroscience 19 465–475.[ISI][Medline]

Pocar P, Augustin R & Fischer B 2004 Constitutive expression of CYP1A1 in bovine cumulus oocyte-complexes in vitro: mechanisms and biological implications. Endocrinology 145 1594–1601.[Abstract/Free Full Text]

Poland A & Knutson JC 1982 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology 22 517–554.[CrossRef][ISI][Medline]

Pollenz RS, Sattler CA & Poland A 1994 The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Molecular Pharmacology 45 428–438.[Abstract]

Pru JK & Tilly JL 2001 Programmed cell death in the ovary: insights and future prospects using genetic technologies. Molecular Endocrinology 15 845–853.[Abstract/Free Full Text]

Puga A, Nebert DW & Carrier F 1992 Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA and Cell Biology 11 269–281.[ISI][Medline]

Puga A, Barnes SJ, Dalton TP, Chang C, Knudsen ES & Maier MA 2000 Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. Journal of Biological Chemistry 275 2943–2950.[Abstract/Free Full Text]

Puga A, Xia Y & Elferink C 2002 Role of the aryl hydrocarbon receptor in cell cycle regulation. Chemico-Biological Interactions 141 117–130.[CrossRef][ISI][Medline]

Reiners JJ Jr & Clift RE 1999 Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells. A function independent of aryl hydrocarbon receptor nuclear translocator. Journal of Biological Chemistry 274 2502–2510.[Abstract/Free Full Text]

Reyes H, Reisz-Porszasz S & Hankinson O 1992 Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256 1193–1195.[Abstract/Free Full Text]

Ricci MS, Toscano DG & Toscano WA Jr 1999 ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function. In Vitro Cell and Developmental Biology. Animal 35 183–189.

Rier SE 2002 The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Annals of the New York Academy of Sciences 955 201–212 Discussion 230–232, 396–406.[Abstract/Free Full Text]

Robles R, Morita Y, Mann KK, Perez GI, Yang S, Matikainen T, Sherr DH & Tilly JL 2000 The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology 141 450–453.[Abstract/Free Full Text]

Safe SH 1986 Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annual Review of Pharmacology and Toxicology 26 371–399.[CrossRef][ISI][Medline]

Safe S & Krishnan V 1995 Chlorinated hydrocarbons: estrogens and antiestrogens. Toxicology Letters 82–83 731–736.[CrossRef]

Safe S, Wormke M & Samudio I 2000 Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. Journal of Mammary Gland Biology and Neoplasia 5 295–306.[CrossRef][ISI][Medline]

Schmidt JV, Su GH, Reddy JK, Simon MC & Bradfield CA 1996 Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. PNAS 93 6731–6736.[Abstract/Free Full Text]

Scott DW, Grdina T & Shi Y 1996 T cells commit suicide, but B cells are murdered! Journal of Immunology 156 2352–2356.[Abstract]

Shiromizu K & Mattison DR 1985 Murine oocyte destruction following intraovarian treatment with 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene: protection by alpha-naphthoflavone. Teratogenesis, Carcinogenesis, and Mutagenesis 5 463–472.[CrossRef][ISI][Medline]

Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HO, Baird DT & Brenner RM 2001 Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. Journal of Clinical Endocrinology and Metabolism 86 2668–2679.[Abstract/Free Full Text]

Son DS, Roby KF, Rozman KK & Terranova PF 2002 Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Toxicology 176 229–243.[CrossRef][ISI][Medline]

Sone H & Yonemoto J 2002 Interaction between dioxin signaling and sex steroid hormones. Journal of Health Science 48 385–392.[CrossRef][ISI]

Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, Sicinski RR & DeLuca HF 2002 A ligand for the aryl hydrocarbon receptor isolated from lung. PNAS 99 14694–14699.[Abstract/Free Full Text]

Stapleton HM & Baker JE 2003 Comparing polybrominated diphenyl ether and polychlorinated biphenyl bioaccumulation in a food web in Grand Traverse Bay, Lake Michigan. Archives of Environmental Contamination and Toxicology 45 227–234.[CrossRef][ISI][Medline]

Van Birgelen AP, Smit EA, Kampen IM, Groeneveld CN, Fase KM, Van der Kolk J, Poiger H, Van den Berg M, Koeman JH & Brouwer A 1995 Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment. European Journal of Pharmacology <